Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Insider-Led Growth Companies To Watch Now

In This Article:

As the U.S. stock market grapples with political and economic uncertainty, leading to a correction in major indices like the S&P 500 and Nasdaq Composite, investors are increasingly seeking stability amidst volatility. In such times, growth companies with high insider ownership can be particularly appealing, as they often signal strong alignment between management and shareholder interests—a crucial factor when navigating turbulent market conditions.

Top 10 Growth Companies With High Insider Ownership In The United States

Name

Insider Ownership

Earnings Growth

Atour Lifestyle Holdings (NasdaqGS:ATAT)

26%

25.6%

Duolingo (NasdaqGS:DUOL)

14.4%

37.1%

Hims & Hers Health (NYSE:HIMS)

13.2%

21.9%

Corcept Therapeutics (NasdaqCM:CORT)

11.7%

36.7%

Astera Labs (NasdaqGS:ALAB)

15.9%

61.1%

Kingstone Companies (NasdaqCM:KINS)

17.9%

24.2%

BBB Foods (NYSE:TBBB)

16.5%

41.1%

Clene (NasdaqCM:CLNN)

20.7%

59.1%

Upstart Holdings (NasdaqGS:UPST)

12.7%

100.1%

Credit Acceptance (NasdaqGS:CACC)

14.4%

33.6%

Click here to see the full list of 207 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

LifeMD

Simply Wall St Growth Rating: ★★★★☆☆

Overview: LifeMD, Inc. is a direct-to-patient telehealth company in the United States that facilitates connections between consumers and healthcare professionals for medical care, with a market cap of $257.25 million.

Operations: The company's revenue segments include $158.44 million from telehealth services and $54.02 million from Worksimpli.

Insider Ownership: 13.8%

LifeMD, Inc. is experiencing rapid revenue growth, with a forecasted annual increase of 19.3%, surpassing the US market average. Despite recent volatility in its share price and significant insider selling over the past quarter, LifeMD's strategic expansions into behavioral health and partnerships like the one with LillyDirect for obesity treatment are bolstering its comprehensive healthcare offerings. The company reported substantial revenue increases for 2024 and expects further growth in 2025, indicating strong potential as it targets profitability within three years.

NasdaqGM:LFMD Ownership Breakdown as at Mar 2025
NasdaqGM:LFMD Ownership Breakdown as at Mar 2025

AppLovin

Simply Wall St Growth Rating: ★★★★★☆

Overview: AppLovin Corporation operates a software-based platform designed to improve marketing and monetization for advertisers globally, with a market cap of $92.67 billion.